Project Grant R34DA065464
Award Date 3/15/26
Completion Date 2/28/29
Dollars Obligated $756K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Bronx, NY 10461, USA
Similar Awards
- Federal Grant Award Summary Albert Einstein College of Medicine received a $199,584 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning March 15, 2026 and concluding February 28, 2031. Under this five-year mentored research and career development award, Dr. Michele Buonora will conduct a hybrid effectiveness-implementation study examining the safety, effectiveness, and implementation of patient-controlled...
- Grant Award Summary New York University School of Medicine received a $771,043 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective March 15, 2026, with a completion date of December 31, 2030. The award funds a hybrid Type II implementation-effectiveness trial conducted in partnership with a peer-led organization in Los Angeles, California, an Ending the HIV Epidemic priority jurisdiction. The primary research...
- Federal Grant Award Summary The University of Miami's Office of Research Administration received a $793,508 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) on March 1, 2026, for a project period extending through January 31, 2031. The award funds STRIVES (Status-Neutral Tele-Health Concierge Intervention for People Who Use Drugs via Engagement Through Street Medicine), a comprehensive telehealth-based care...
- Federal Project Grant Award Summary The University of California, San Diego has received a $1.57 million Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded August 1, 2025, with completion targeted for April 30, 2030. The grant funds a hybrid Type I trial titled "Breaking Barriers: Innovating HIV Elimination with Social Network Strategies and Routine Substance Use Screening," which will be conducted at...
- Federal Grant Award Summary Columbia University received a $246,012 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, through June 30, 2028. The project will develop and evaluate a digital crowdsourced intervention designed to increase HIV, sexually transmitted infection (STI), and hepatitis C virus (HCV) testing uptake and overdose prevention kit utilization among survivors of sex...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Alabama at Birmingham $1,465,275 under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research on the molecular mechanisms by which HIV and HIV proteins enhance amphetamine use disorder (AUD) escalation. The research project, initiated May 1, 2025 and extending through March 31, 2030, addresses a critical knowledge gap in understanding the bidirectional relationship...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Feinstein Institutes For Medical Research a $616,372 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning July 15, 2025, with a completion date of March 31, 2030. This award supports research investigating transposable element (TE) expression and regulation in the context of HIV-1 infection and cannabinoid exposure at the single-cell and nuclei level. The research leverages a...
- Federal Grant Award Summary The Scripps Research Institute received a $608,652 Project Grant award dated September 1, 2025, from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct data mining and functional validation of SCORCH (Single Cell Omics Research Center for HIV) datasets through May 31, 2030. The research initiative will deliver comparative analysis of cell type-specific gene regulatory networks derived from human and...
- Federal Grant Award Summary The University of Miami received a $677,248 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a randomized controlled trial (RCT) testing the Comprehensive Telehealth Concierge (C-THR) model. The award, effective February 15, 2026, through December 31, 2030, focuses on improving HIV prevention and substance use disorder treatment engagement among individuals with histories...
- Federal Grant Award Summary Icahn School of Medicine at Mount Sinai received a $2.352 million Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct neurogenomic research on HIV-exposed brains in the context of opioid and substance use disorder comorbidity. The award, effective February 15, 2026, through January 31, 2030, will deliver two primary research products: (1) single-molecule functional validation of...